Stocks and InvestingStocks and Investing
Mon, June 13, 2022
Sun, June 12, 2022
Fri, June 10, 2022
Thu, June 9, 2022
Wed, June 8, 2022
Tue, June 7, 2022

Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $6 on, Jun 7th, 2022


Published on 2024-10-27 21:25:45 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $19 to $6 on, Jun 7th, 2022.

Jonathan has made no other calls on VINC in the last 4 months.



There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Wednesday, March 30th, 2022